Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.

Article  Google Scholar 

Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544–73. https://doi.org/10.1002/cncr.24760.

Article  PubMed  PubMed Central  Google Scholar 

Garborg K, Holme Ø, Løberg M, Kalager M, Adami HO, Bretthauer M. Current status of screening for colorectal cancer. Ann Oncol. 2013;24(8):1963–72. https://doi.org/10.1093/annonc/mdt157.

CAS  Article  PubMed  Google Scholar 

Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2009;27(6):872–7. https://doi.org/10.1200/JCO.2008.19.5362.

Article  PubMed  PubMed Central  Google Scholar 

Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–17. https://doi.org/10.3322/caac.21220.

Article  PubMed  Google Scholar 

Diaz LA, Uram JN, Wang H, Bartlett B, Kemberling H, Eyring A, et al. Programmed death-1 blockade in mismatch repair deficient cancer independent of tumor histology. J Clin Oncol. 2016;34(15_suppl):3003. https://doi.org/10.1200/JCO.2016.34.15_suppl.3003.

Article  Google Scholar 

Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372(26):2509–20. https://doi.org/10.1056/NEJMoa1500596.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz H-J, Morse MA, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017;18(9):1182–91. https://doi.org/10.1016/S1470-2045(17)30422-9.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58(22):5248–57.

CAS  PubMed  Google Scholar 

Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960–4. https://doi.org/10.1126/science.1129139.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409–13. https://doi.org/10.1126/science.aan6733.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23(3):609–18. https://doi.org/10.1200/JCO.2005.01.086.

CAS  Article  PubMed  Google Scholar 

Venderbosch S, Nagtegaal ID, Maughan TS, Smith CG, Cheadle JP, Fisher D, et al. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies. Clin Cancer Res. 2014;20(20):5322–30. https://doi.org/10.1158/1078-0432.CCR-14-0332.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2018;36(17):1714–68. https://doi.org/10.1200/JCO.2017.77.6385.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Overman MJ, Lonardi S, Wong KYM, Lenz H-J, Gelsomino F, Aglietta M, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol. 2018;36(8):773–9. https://doi.org/10.1200/JCO.2017.76.9901.

CAS  Article  PubMed  Google Scholar 

Kim D, Zeng MY, Núñez G. The interplay between host immune cells and gut microbiota in chronic inflammatory diseases. Exp Mol Med. 2017;49(5):e339-e. https://doi.org/10.1038/emm.2017.24.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Czesnikiewicz-Guzik M, Müller DN. Scientists on the spot: salt, the microbiome, and cardiovascular diseases. Cardiovasc Res. 2018;114(10):e72–e3. https://doi.org/10.1093/cvr/cvy171.

CAS  Article  PubMed  Google Scholar 

Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016;7:12015. https://doi.org/10.1038/ncomms12015.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Khanna S, Montassier E, Schmidt B, Patel R, Knights D, Pardi DS, et al. Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection. Aliment Pharmacol Ther. 2016;44(7):715–27. https://doi.org/10.1111/apt.13750.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Hansen JJ, Sartor RB. Therapeutic manipulation of the microbiome in IBD: current results and future approaches. Curr Treat Options Gastroenterol. 2015;13(1):105–20. https://doi.org/10.1007/s11938-014-0042-7.

Article  PubMed  PubMed Central  Google Scholar 

Tierney BT, He Y, Church GM, Segal E, Kostic AD, Patel CJ. The predictive power of the microbiome exceeds that of genome-wide association studies in the discrimination of complex human disease. bioRxiv. 2020:2019.12.31.891978. https://doi.org/10.1101/2019.12.31.891978.

Salosensaari A, Laitinen V, Havulinna AS, Meric G, Cheng S, Perola M, et al. Taxonomic signatures of long-term mortality risk in human gut microbiota. medRxiv. 2020:2019.12.30.19015842. https://doi.org/10.1101/2019.12.30.19015842.

Garrett WS. Cancer and the microbiota. Science. 2015;348(6230):80–6. https://doi.org/10.1126/science.aaa4972.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Tsilimigras MCB, Fodor A, Jobin C. Carcinogenesis and therapeutics: the microbiota perspective. Nat Microbiol. 2017;2:17008. https://doi.org/10.1038/nmicrobiol.2017.8.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Di Domenico EG, Cavallo I, Pontone M, Toma L, Ensoli F. Biofilm producing Salmonella typhi: chronic colonization and development of gallbladder cancer. Int J Mol Sci. 2017;18(9):1887. https://doi.org/10.3390/ijms18091887.

CAS  Article  PubMed Central  Google Scholar 

Huang Y, Fan XG, Wang ZM, Zhou JH, Tian XF, Li N. Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol. 2004;57(12):1273–7. https://doi.org/10.1136/jcp.2004.018556.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345(2):196–202. https://doi.org/10.1016/j.canlet.2013.08.016.

CAS  Article  PubMed  Google Scholar 

Ishaq S, Nunn L. Helicobacter pylori and gastric cancer: a state of the art review. Gastroenterol Hepatol Bed Bench. 2015;8(Suppl 1):S6–S14.

PubMed  PubMed Central  Google Scholar 

Gold JS, Bayar S, Salem RR. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg. 2004;139(7):760–5. https://doi.org/10.1001/archsurg.139.7.760.

Article  PubMed  Google Scholar 

Mima K, Nakagawa S, Sawayama H, Ishimoto T, Imai K, Iwatsuki M, et al. The microbiome and hepatobiliary-pancreatic cancers. Cancer Lett. 2017;402:9–15. https://doi.org/10.1016/j.canlet.2017.05.001.

CAS  Article  PubMed  Google Scholar 

García-Castillo V, Sanhueza E, McNerney E, Onate SA, García A. Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle. J Med Microbiol. 2016;65(12):1347–62. https://doi.org/10.1099/jmm.0.000371.

CAS  Article  PubMed  Google Scholar 

Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178(4):795–806.e12. https://doi.org/10.1016/j.cell.2019.07.008.

CAS  Article  PubMed  Google Scholar 

Flemer B, Lynch DB, Brown JMR, Jeffery IB, Ryan FJ, Claesson MJ, et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut. 2017;66(4):633–43. https://doi.org/10.1136/gutjnl-2015-309595.

CAS  Article  PubMed  Google Scholar 

Scott AJ, Alexander JL, Merrifield CA, Cunningham D, Jobin C, Brown R, et al. International cancer microbiome consortium consensus statement on the role of the human microbiome in carcinogenesis. Gut. 2019;68(9):1624–32. https://doi.org/10.1136/gutjnl-2019-318556.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Purcell RV, Pearson J, Aitchison A, Dixon L, Frizelle FA, Keenan JI. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia. PLoS One. 2017;12(2):e0171602-e. https://doi.org/10.1371/journal.pone.0171602.

CAS  Article  PubMed  PubMed Central